NCT06922825View on ClinicalTrials.gov

Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

April 30, 2029

Study Completion Date

September 30, 2032

Conditions
Solid Tumor CancerSolid Tumor MalignancyCancerMalignancy
Interventions
DRUG

68Ga-FAPI-46

Participants will receive an IV injection of 68Ga-FAPI-46. Then, shortly after will undergo a PET/CT imaging using the 68Ga-FAPI-46. Additionally, MRI or contrast CT imaging will be conducted, either on the same day or within 14 days.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

Vanderbilt University Medical Center

OTHER

collaborator

Vanderbilt-Ingram Cancer Center

OTHER

lead

Eben Rosenthal

OTHER